Trial Profile

A Study to Assess the Effects of 2 Prothrombin Complex Concentrates on the Pharmacodynamics of Apixaban in Healthy Adult Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 01 Sep 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Apixaban (Primary) ; Prothrombin complex concentrate
Indications Acute coronary syndromes; Deep vein thrombosis; Pulmonary embolism; Stroke; Venous thromboembolism
Focus Pharmacodynamics
Sponsors Bristol-Myers Squibb

Most Recent Events

28 Aug 2017 Results published in the Journal of Thrombosis and Haemostasis
14 Jan 2015 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
05 Mar 2014 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com